A NEW GENE THERAPY PARADIGM IN VIVO CRISPR ENGINEERING OF HEMATOPOIETIC NICHES FOR CANCER IMMUNOTHERAPY. (2026). Frontier in Medical and Health Research, 4(6), 1756-1802. https://fmhr.net/index.php/fmhr/article/view/3230